Dlh / vlastný kapitál spoločnosti Hutchison China MediTech
Aká je hodnota metriky Dlh / vlastný kapitál spoločnosti Hutchison China MediTech?
Hodnota metriky Dlh / vlastný kapitál spoločnosti Hutchison China MediTech Ltd. je 0.72
Aká je definícia metriky Dlh / vlastný kapitál?
Dlh / vlastný kapitál (Debt to equity ratio) ukazovateľ vyjadruje pomer vlastného kapitálu a cudzích zdrojov na financovanie majetku spoločnosti.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dlh / vlastný kapitál spoločností v sektore Health Care sektor na LSE v porovnaní so spoločnosťou Hutchison China MediTech
Čomu sa venuje spoločnosť Hutchison China MediTech?
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases worldwide. It operates in two segments, Oncology/Immunology and Other Ventures. It manufactures, distributes, markets, and sells prescription and over-the-counter pharmaceutical, and consumer health products. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and clear cell renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors. It also develops Surufatinib, an inhibitor for neuroendocrine tumors (NET), pancreatic NET, non-pancreatic NET, biliary tract cancer, sarcoma, neuroendocrine neoplasm, esophageal cancer, small cell lung cancer, GC, thyroid cancer, EMC, NSCLC, and solid tumors; HMPL-523, an inhibitor for indolent non-Hodgkin's lymphoma (NHL), B-cell malignancies, and immune thrombocytopenic purpura; and HMPL-689 for indolent non-Hodgkin's, follicular, marginal zone, mantle cell, diffuse large B cell, chronic lymphocytic leukemia/small lymphocytic, and Hodgkin's lymphoma. The company develops HMPL-453, an inhibitor for intrahepatic cholangiocarcinoma; HMPL-306, an inhibitor for hematological malignancies, gliomas, and solid tumors; HMPL-295 for solid tumors; and HMPL-813 and HMPL-309 EGFR inhibitors. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, BeiGene, Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics (Suzhou) Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Central, Hong Kong.
Firmy s metrikou dlh / vlastný kapitál podobnou spoločnosti Hutchison China MediTech
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Informa Plc je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Ashok Alco-Chem je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti YASKAWA Electric je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Warehouses De Pauw SCA je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Warehouses De Pauw NV je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti CyanConnode plc je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Hutchison China MediTech je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Universal Security Instruments je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Zimmer Biomet Inc je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Oriental Trimex je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Buru je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti American Homes 4 Rent je 0.72
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Langham Hospitality Investments je 0.72